Drug Discovery World

MAY 1, 2024

This is reflected in collaboration and investment patterns; in 2023, Antiverse, a biotechnology company developing a computational antibody drug discovery platform, raised seed funding totalling £1.4 million, comprising new investment and match funding from the UKI2S Innovate Accelerator.

FDA Approval 147

FDA Approval Therapies FDA Molecular Biology 147

Drug Discovery World

AUGUST 7, 2024

Ashu Singhal and Sajith Wickramasekara , co-founders of Benchling, explore how AI’s true promise for the pharmaceutical industry can only be realised if the entire pharmaceutical R&D lifecycle is supported. Pharma R&D has been heading in the wrong direction, becoming progressively less efficient over the last few decades.

Pharma R&D 173

Pharma R&D Clinical Trials Pharma Companies Trials 173

Drug Discovery World

JULY 19, 2023

Bioinformatics and genetic sequencing are starting to be placed front and centre of public research programmes as scientists from around the world recognise the substantial benefits of knowledge sharing and resource pooling when it comes to genetic science. The tide has been turning in the worlds of diagnostics and drug development.

Science 130

Science Bioinformatics Disease Pharma Companies 130

The Open Targets Blog

OCTOBER 24, 2023

Amir Feizi is the Director of Bioinformatics at OMass Therapeutics, a spinout from Professor Dame Carol Robinson’s Laboratory at the University of Oxford. Their work was recently published in Bioinformatics. We chat with him about otargen, and the importance of sharing open-source resources within the bioinformatics community.

Bioinformatics 64

Bioinformatics Packaging Pharmaceutical Companies Pharma Companies 64

Elrig

APRIL 29, 2024

Harini Srinivasan is a Principal Scientific Associate at Serna Bio with over 10 years of research experience in academic institutions, health care organizations and pharmaceutical companies. Bioinformatics is all about bringing together different areas of knowledge. big pharma or startups/spin off? What pro/cons?

Bioinformatics 59

Bioinformatics Molecular Biology Drugs Cell Based Assays 59

Drug Discovery World

NOVEMBER 15, 2022

If a pharmaceutical company is racing to identify a new vaccine, for instance, then waiting for three weeks to receive DNA sequences each time can slow down the development process compared to competitors who might have faster timelines.” . “We Cell-free systems for drug design and manufacturing .

DNA 246

DNA Engineering Drugs Vaccine 246